Huwm Nash News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Huwm nash. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Huwm Nash Today - Breaking & Trending Today

Head to Head Survey: Agios Pharmaceuticals (NASDAQ:AGIO) and Aileron Therapeutics (NASDAQ:ALRN)

Aileron Therapeutics (NASDAQ:ALRN – Get Rating) and Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, risk, dividends and valuation. Analyst Ratings This is a summary of current ratings […] ....

United Kingdom , Lewis Clayton Cantley , Huwm Nash , Josepha Yanchik , Craigb Thompson , Gregoryl Verdine , Rosana Kapeller , Loren David Walensky , Aileron Therapeutics Inc , Agios Pharmaceuticals Inc , Agios Pharmaceuticals , Aileron Therapeutics , Get Rating , Given Agios Pharmaceutical , Agios Pharmaceutical , Aileron Therapeutics Daily , Nasdaq Alrn , Stock Comparison , Stock Analysis ,

Analysts Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $47.20

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) has earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among […] ....

United States , Adrianr Krainer , Huwm Nash , Isabel Aznarez , Securities Exchange Commission , Life Insurance Co , Zacks Investment Research , Stoke Therapeutics Inc , Stoke Therapeutics Company Profile Get Rating , Invesco Ltd , Connor Clark Lunn Investment Management Ltd , Jefferies Financial Group , Healthcare Of Ontario Pension Plan Trust Fund , Stoke Therapeutics , Get Rating , Marketbeat Ratings , Financial Group , Investment Research , Exchange Commission , Ontario Pension Plan Trust Fund , Lunn Investment Management , Therapeutics Company Profile , Nasdaq Stok ,

Stoke Therapeutics (NASDAQ:STOK) Lowered to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Stoke Therapeutics (NASDAQ:STOK – Get Rating) from a buy rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company’s product candidate consists of STK-001 […] ....

United States , Adrianr Krainer , Huwm Nash , Isabel Aznarez , Securities Exchange Commission , Goldman Sachs Group Inc , Zacks Investment Research , Nuveen Asset Management , Stoke Therapeutics Inc , Highvista Strategies , Jpmorgan Chase Co , Jefferies Financial Group , Stoke Therapeutics , Get Rating , Exchange Commission , Sachs Group , Asset Management , State Teachers Retirement System , Vista Strategies , State Street Corp , Street Corp , Nasdaq Stok ,